Literature DB >> 23769537

Complexation of fisetin with novel cyclosophoroase dimer to improve solubility and bioavailability.

Daham Jeong1, Jae Min Choi, Youngjin Choi, Karpjoo Jeong, Eunae Cho, Seunho Jung.   

Abstract

Rhizobium species produce cyclosophoraose (Cys), which is an unbranched cyclic β-(1,2)-glucan. We synthesized novel cationic cyclosophoraose dimer (Cys dimer) and its structure was confirmed via NMR spectroscopy and MALDI-TOF mass spectrometry analysis. In this study, we investigated the complexation of hardly soluble drug fisetin (3,3',4',7-tetrahydroxyflavone) with Cys dimer to improve the solubility of fisetin, and its solubility was increased up to 6.5-fold. The solubility of fisetin with Cys dimer showed 2.4-fold better than with β-cyclodextrin. The fisetin-Cys dimer complex was characterized by using, phase solubility diagram, 2D NMR, FT-IR spectroscopy, SEM, DSC analysis and molecular modeling. Through the molecular docking simulations, complexation ability of fisetin with host molecules were in the following order: Cys dimer>Cys monomer>β-CD. The fisetin-Cys dimer complex showed also higher cytotoxicity to HeLa cells than free fisetin, indicating that the Cys dimer to improve bioavailability of fisetin.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23769537     DOI: 10.1016/j.carbpol.2013.04.066

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  6 in total

Review 1.  Exploring the molecular targets of dietary flavonoid fisetin in cancer.

Authors:  Deeba N Syed; Vaqar Mustafa Adhami; Naghma Khan; Mohammad Imran Khan; Hasan Mukhtar
Journal:  Semin Cancer Biol       Date:  2016-05-06       Impact factor: 15.707

Review 2.  Flavonoids-Based Delivery Systems towards Cancer Therapies.

Authors:  Miguel Ferreira; Diana Costa; Ângela Sousa
Journal:  Bioengineering (Basel)       Date:  2022-05-02

3.  Fisetin glycosides synthesized by cyclodextrin glycosyltransferase from Paenibacillus sp. RB01: characterization, molecular docking, and antioxidant activity.

Authors:  Nattawadee Lorthongpanich; Panupong Mahalapbutr; Thanyada Rungrotmongkol; Thanapon Charoenwongpaiboon; Manchumas Hengsakul Prousoontorn
Journal:  PeerJ       Date:  2022-05-24       Impact factor: 3.061

4.  Enhanced oral bioavailability and anticancer efficacy of fisetin by encapsulating as inclusion complex with HPβCD in polymeric nanoparticles.

Authors:  Amrita Kadari; Sagarika Gudem; Hitesh Kulhari; Murali Mohan Bhandi; Roshan M Borkar; Venkata Ramana Murthy Kolapalli; Ramakrishna Sistla
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

5.  Solid-state studies and antioxidant properties of the γ-cyclodextrin·fisetin inclusion compound.

Authors:  Joana M Pais; Maria João Barroca; Maria Paula M Marques; Filipe A Almeida Paz; Susana S Braga
Journal:  Beilstein J Org Chem       Date:  2017-10-13       Impact factor: 2.883

Review 6.  New Perspectives for Fisetin.

Authors:  Grzegorz Grynkiewicz; Oleg M Demchuk
Journal:  Front Chem       Date:  2019-10-30       Impact factor: 5.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.